FDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity
The Pharma Data
JULY 29, 2021
Food and Drug Administration (FDA) has approved a label expansion of BOTOX ® to include eight new muscles for the treatment of upper limb spasticity in adults. Tell your doctor if you have any breathing-related problems. Tell your doctor if you have any breathing-related problems. million adults in the U.S.
Let's personalize your content